Olga M. Klibanov
- Infectious Diseases top 10%
- Virology top 5%
- Epidemiology
- Hepatology top 10%
- Molecular Biology
- Co-authors
- Jacqueline L. OlinLinda M. SpoonerStephen F EckelJohn RubleinRalph H. RaaschJoanne FilickoJoseph DeSimoneLisa Smith
- Topics
- HIV/AIDS drug development and treatment (14 papers)HIV Research and Treatment (11 papers)Hepatitis C virus research (7 papers)
- Journals
- Journal of Pharmacy and PharmacologyPharmacotherapy The Journal of Human Pharmacology and Drug TherapyDermatologic Surgery
- Partner nations
- United StatesGermanySingapore
In The Last Decade
Olga M. Klibanov
28 papers receiving 381 citations
Peers
Comparison fields: 5 of 90
- Infectious Diseases 174
- Virology 111
- Epidemiology 106
- Hepatology 76
- Molecular Biology 64
Countries citing papers authored by Olga M. Klibanov
This map shows the geographic impact of Olga M. Klibanov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga M. Klibanov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga M. Klibanov more than expected).
Fields of papers citing papers by Olga M. Klibanov
This network shows the impact of papers produced by Olga M. Klibanov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga M. Klibanov. The network helps show where Olga M. Klibanov may publish in the future.
Co-authorship network of co-authors of Olga M. Klibanov
This figure shows the co-authorship network connecting the top 25 collaborators of Olga M. Klibanov. A scholar is included among the top collaborators of Olga M. Klibanov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga M. Klibanov. Olga M. Klibanov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 5 | |
| 3 | 3 | |
| 4 | 22 | |
| 5 | 4 | |
| 6 | 0 | |
| 7 | 41 | |
| 8 | 4 | |
| 9 | 3 | |
| 10 | 19 | |
| 11 | 22 | |
| 12 | 8 | |
| 13 | Cenicriviroc, an orally active CCR5 antagonist for the potential treatment of HIV infection. | 30 |
| 14 | 18 | |
| 15 | 2 | |
| 16 | 24 | |
| 17 | 2 | |
| 18 | 3 | |
| 19 | 3 | |
| 20 | 24 |
About Olga M. Klibanov
Olga M. Klibanov is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 29 papers that have together received 392 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (14 papers), HIV Research and Treatment (11 papers) and Hepatitis C virus research (7 papers). The work is most often cited by research in Virology (111 citations), Hepatology (76 citations) and Infectious Diseases (174 citations). Olga M. Klibanov has collaborated with scholars based in United States, Germany and Singapore. Frequent co-authors include Jacqueline L. Olin, Linda M. Spooner, Stephen F Eckel, John Rublein, Ralph H. Raasch, Joanne Filicko, Joseph DeSimone, Lisa Smith, Mary van den Berg-Wolf and John P. Gaughan. Their work appears in journals such as Journal of Pharmacy and Pharmacology, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy and Dermatologic Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.